Schedule 13G ownership disclosure

Cidara Therapeutics, Inc.

Security class unavailable

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
594,595
Percent of class
3.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001105806-17-000005
Form type
SC 13G/A
Filer
Cidara Therapeutics, Inc.
CIK
CIK 1610618
Filed
Feb 14, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub